Smartcard Helps Communicate Radiation Risks
The radiology department at the University of Colorado in Denver has developed pocket-sized reference card that provides the effective doses and radiation risks of common adult radiologic exams.
The radiology department at the University of Colorado in Denver has developed pocket-sized reference card that provides the effective doses and radiation risks of common adult radiologic exams.
The Adult Dose-Risk Smartcard aims to help referring physicians and patients make more informed decisions about related risks of undergoing or refusing to undergo common radiological examinations. A report of the smartcard was published in the April issue of the Journal of the American College of Radiology.
The smartcard allows the patients to compare doses from various radiologic exams to background radiation, and it provides information on risks of fatal radiation-induced cancer, as last reported by the International Commission on Radiological Protection.
The new tool may be useful in helping patients make decisions, but it does have its drawbacks.
“We recognize that there may be significant age-dependent and gender-dependent variations in both radiation dose and risk estimates,” said R. Edward Hendrick, PhD, lead author of the article. “The Adult Dose-Risk Smartcard does not attempt to incorporate all those variations, but instead to communicate a representative estimate of effective doses and radiations to adults from various radiologic procedures.”
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
